Stay updated with breaking news from Formycon Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Formycon, a Germany-based biosimilar manufacturer, shared that its revenues for 2023 were 83% higher than in 2022, reaching a total of €77.7 million, according to its annual earnings report.
EQS-News: Formycon AG / Key word: Preliminary Results/Forecast Convincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds...
EQS-News: Formycon AG / Key word(s): Preliminary Results/ForecastConvincing overall performance - Formycon reports preliminary results for the financial year 2023 and exceeds forecast 12.04.2024 / 22:15 CET/CESTThe issuer is solely responsible for the content of this announcement.Press release // 12 April 2024 ...
EQS-News: Formycon AG / Key word(s): 9 Month figures/Quarterly / Interim Statement Formycon publishes nine-month results for...
EQS-News: Formycon AG / Key word(s): Half Year Results/Half Year ReportFormycon reports successful first half of 2023 30.08.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release // August 30, 2023Formycon reports successful first half of 2023 Development of biosimil...